A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance ...

European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...

Enrollment and dosing underway in Phase 3 clinical trial (the“MIRACLE” trial) evaluating Annamycin (naxtarubicin) for the treatment of R/R AML </p ...

The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...

Aurobindo Pharma's CuraTeQ Biologics receives marketing authorization for Zefylti filgrastim biosimilar in the UK and EU.

EMERYVILLE, Calif. , May 13, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator ...

Ireland’s Health and Safety Executive has criticised a new report revealing the country’s shocking last place in Western Europe for new oncology drug access.

Antibiotic use in the first 3 month of life was associated with a 23% increase in risk of early puberty in girls.

New research reveals the potential of drugs that have been on the market for decades to treat diseases other than those for ...

An EU committee is recommending that tranilast, the active ingredient in a pulmonary fibrosis drug candidate, be awarded ...